Outset Medical, Inc.
OM
$4.56
$0.122.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.67% | 14.72% | 5.62% | -3.41% | -5.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.67% | 14.72% | 5.62% | -3.41% | -5.59% |
| Cost of Revenue | -5.33% | 11.05% | -4.88% | -19.96% | -18.78% |
| Gross Profit | 18.02% | 21.31% | 29.84% | 44.45% | 37.21% |
| SG&A Expenses | -13.69% | -23.92% | -29.05% | -29.22% | -30.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.83% | -16.97% | -25.70% | -29.94% | -30.75% |
| Operating Income | 33.67% | 45.18% | 51.68% | 53.17% | 47.55% |
| Income Before Tax | 37.19% | 46.25% | 35.48% | 33.38% | 39.78% |
| Income Tax Expenses | 121.98% | -31.13% | -29.01% | -103.57% | 111.63% |
| Earnings from Continuing Operations | 36.16% | 46.19% | 35.45% | 33.58% | 39.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.16% | 46.19% | 35.45% | 33.58% | 39.50% |
| EBIT | 33.67% | 45.18% | 51.68% | 53.17% | 47.55% |
| EBITDA | 34.06% | 46.37% | 53.49% | 55.36% | 48.97% |
| EPS Basic | 87.49% | 89.51% | 68.88% | 36.71% | 42.21% |
| Normalized Basic EPS | 87.70% | 89.53% | 76.45% | 46.77% | 42.48% |
| EPS Diluted | 87.49% | 89.51% | 68.88% | 36.71% | 42.21% |
| Normalized Diluted EPS | 87.70% | 89.53% | 76.45% | 46.77% | 42.48% |
| Average Basic Shares Outstanding | 410.42% | 413.10% | 107.43% | 4.95% | 4.70% |
| Average Diluted Shares Outstanding | 410.42% | 413.10% | 107.43% | 4.95% | 4.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |